Volume 8, Issue 4 pp. 322-328

The use of multiple transbronchial biopsies as the standard approach to evaluate lung allograft rejection

Albert Faro

Albert Faro

Department of Pediatrics, University of Florida, Gainesville, FL, USA

Search for more papers by this author
Gary Visner

Gary Visner

Department of Pediatrics, University of Florida, Gainesville, FL, USA

Search for more papers by this author
First published: 19 July 2004
Citations: 35
Albert Faro MD, Assistant Professor, Division of Pediatric Pulmonary Medicine, Department of Pediatrics, University of Florida, Box 100296, Gainesville, FL 32610, USA
Tel.: 352 392 4458
Fax: 352 392 4450
E-mail: [email protected]

Abstract

Abstract: Flexible bronchoscopy with transbronchial biopsy (TBB) is routinely performed in adult and pediatric lung transplant recipients. The clinical signs and symptoms of acute cellular rejection (ACR) are often identical to those of infection. TBB is a fairly sensitive and specific tool in which to diagnose ACR and can be performed safely in children of all ages. The utility of TBB is unquestioned during periods of worsening clinical symptoms. The utility of TBB for routine surveillance of the allograft remains unproven. The data suggests that during the first 4–6 months post-transplant there is a high incidence of clinically silent ACR. The significance of subclinical rejection in lung transplantation is unknown. Randomized, controlled trials are required to determine if multiple surveillance TBB, can impact the incidence of obliterative bronchiolitis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.